Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F03%3A00009172" target="_blank" >RIV/00023736:_____/03:00009172 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1038/sj.leu.2403068" target="_blank" >http://dx.doi.org/10.1038/sj.leu.2403068</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/sj.leu.2403068" target="_blank" >10.1038/sj.leu.2403068</a>
Alternative languages
Result language
angličtina
Original language name
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
Original language description
We studied 128 patients with chronic myeloid leukemia (CML) relapsing after allogeneic stem cell transplantation (SCT). Disease at the time of treatment with Imatinib was in chronic phase (CP) in 51 patients, accelerated phase (AP) in 31 and blastic crisis (BC) in 46. Of the 51 patients in CP, 14 were in cytogenetic and two in molecular relapses. The median interval between relapse and Imatinib therapy was 5 months (0-65).
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2003
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia
ISSN
0887-6924
e-ISSN
—
Volume of the periodical
17
Issue of the periodical within the volume
9
Country of publishing house
GB - UNITED KINGDOM
Number of pages
6
Pages from-to
1707-1712
UT code for WoS article
000185335600004
EID of the result in the Scopus database
—